Literature DB >> 3061409

Ultrastructural morphometric analysis of endomyocardial biopsies. Idiopathic dilated cardiomyopathy, anthracycline cardiotoxicity, and normal myocardium.

R A Rowan1, M A Masek, M E Billingham.   

Abstract

Anthracycline cardiotoxicity has been regarded as a model of idiopathic dilated cardiomyopathy, and similar histopathologic changes have been described in both. Our purpose was to quantify these changes, using computer-assisted ultrastructural morphometry, and compare them with normal myocardium. Right ventricular endomyocardial biopsies were taken from 10 patients with anthracycline cardiotoxicity (AC), 10 patients with idiopathic dilated cardiomyopathy (CM), and 10 disease-free transplant donor heart controls (C). Mean myocyte width (corrected for sarcomere length) was significantly greater in CM (29.3 microns +/- 7.2) than in AC (19.2 +/- 3.2) or C (20.3 +/- 3.4). Mean nuclear area was significantly greater in CM (88.7 microns 2 +/- 27.1) than in AC (54.2 +/- 15.3) or C (45.0 +/- 9.2). Nuclear form factor (corrected for sarcomere length) was significantly lower (indicating a more irregular outline) in CM (0.28 +/- 0.09) than in AC (0.46 +/- 0.06) or C (0.36 +/- 0.04). Mean mitochondrial area was significantly smaller in CM (0.30 microns 2 +/- 0.05) than in C (0.35 +/- 0.05), but differences between AC (0.35 +/- 0.09) and the other groups were not significant. These results suggest that anthracycline cardiotoxicity is not, quantitatively, a faithful model of idiopathic dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3061409

Source DB:  PubMed          Journal:  Am J Cardiovasc Pathol        ISSN: 0887-8005


  6 in total

Review 1.  Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?

Authors:  Douglas B Sawyer; Xuyang Peng; Billy Chen; Laura Pentassuglia; Chee Chew Lim
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

2.  Morphometric comparison of mitochondria and myofibrils of cardiomyocytes between hypertrophic and dilated cardiomyopathies.

Authors:  A Tashiro; T Masuda; I Segawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.

Authors:  Pallavi Gupta; Zofia T Bilinska; Nicolas Sylvius; Emilie Boudreau; John P Veinot; Sarah Labib; Pierrette M Bolongo; Akil Hamza; Tracy Jackson; Rafal Ploski; Michal Walski; Jacek Grzybowski; Ewa Walczak; Grzegorz Religa; Anna Fidzianska; Frédérique Tesson
Journal:  Basic Res Cardiol       Date:  2010-02-03       Impact factor: 17.165

4.  Cellular hypertrophy in cardiomyopathic patients is associated with lower creatine-stimulated mitochondrial respiration.

Authors:  M Popovich; S Kostin; T Branishte; V Kobets; V Kapelko
Journal:  Mol Cell Biochem       Date:  1995-02-09       Impact factor: 3.396

5.  Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.

Authors:  S Romano; S Fratini; E Ricevuto; V Procaccini; G Stifano; M Mancini; M Di Mauro; C Ficorella; M Penco
Journal:  Br J Cancer       Date:  2011-11-08       Impact factor: 7.640

6.  Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies.

Authors:  David Montaigne; Christopher Hurt; Remi Neviere
Journal:  Biochem Res Int       Date:  2012-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.